Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 40

1.

In vitro cytotoxicity of novel platinum-based drugs and dichloroacetate against lung carcinoid cell lines.

Fiebiger W, Olszewski U, Ulsperger E, Geissler K, Hamilton G.

Clin Transl Oncol. 2011 Jan;13(1):43-9. doi: 10.1007/s12094-011-0615-z.

PMID:
21239354
2.

Neuroendocrine carcinomas arising in solid-organ transplant recipients: rare but aggressive malignancies.

Fiebiger W, Kaserer K, Rodler S, Oberbauer R, Bauer C, Raderer M.

Oncology. 2009;77(5):314-7. doi: 10.1159/000260058. Epub 2009 Nov 20.

PMID:
19940522
3.

Closed suctioning system reduces cross-contamination between bronchial system and gastric juices.

Rabitsch W, Köstler WJ, Fiebiger W, Dielacher C, Losert H, Sherif C, Staudinger T, Seper E, Koller W, Daxböck F, Schuster E, Knöbl P, Burgmann H, Frass M.

Anesth Analg. 2004 Sep;99(3):886-92, table of contents.

PMID:
15333426
4.
5.

Health-related quality of life outcomes after kidney transplantation.

Fiebiger W, Mitterbauer C, Oberbauer R.

Health Qual Life Outcomes. 2004 Jan 8;2:2. Review.

6.

Rituximab for treatment of advanced extranodal marginal zone B cell lymphoma of the mucosa-associated lymphoid tissue lymphoma.

Raderer M, Jäger G, Brugger S, Püspök A, Fiebiger W, Drach J, Wotherspoon A, Chott A.

Oncology. 2003;65(4):306-10.

PMID:
14707449
7.

Occurrence of a pulmonary carcinoid following allogeneic stem cell transplantation for chronic myelogenous leukemia: a case report.

Fiebiger W, Kurtaran A, Novotny C, Kainberger F, Dekan G, Raderer M.

Ann Hematol. 2003 Jun;82(6):374-6. Epub 2003 Apr 29.

PMID:
12719884
8.
9.

Complete remission of chronic plaque psoriasis and gastric marginal zone B-cell lymphoma of MALT type after treatment with 2-chlorodeoxyadenosine.

Valencak J, Trautinger F, Fiebiger WC, Raderer M.

Ann Hematol. 2002 Nov;81(11):662-5. Epub 2002 Oct 29. Review.

PMID:
12454707
10.

Comparison of spiral-computed tomography with water-filling of the stomach and endosonography for gastric lymphoma of mucosa-associated lymphoid tissue-type.

Vorbeck F, Osterreicher C, Püspök A, Dragosics B, Fiebiger W, Chott A, Raderer M.

Digestion. 2002;65(4):196-9.

PMID:
12239459
11.

Phase II study with docetaxel and cisplatin in the treatment of recurrent and/or metastatic squamous cell carcinoma of the head and neck.

Gedlicka C, Formanek M, Selzer E, Burian M, Kornfehl J, Fiebiger W, Cartellieri M, Marks B, Kornek GV.

Oncology. 2002;63(2):145-50.

PMID:
12239449
12.

Second-Line Treatment of Advanced Colorectal Cancer with a Biweekly Oxaliplatin plus Irinotecan Combination Regimen.

Schüll B, Kornek GV, Schmid K, Raderer M, Ulrich-Pur H, Fiebiger W, Schneeweiss B, Lenauer A, Depisch D, Scheithauer W.

Onkologie. 2002 Aug;25(4):358-62.

PMID:
12232488
13.

Treatment of extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue type with cladribine: a phase II study.

Jäger G, Neumeister P, Brezinschek R, Hinterleitner T, Fiebiger W, Penz M, Neumann HJ, Mlineritsch B, DeSantis M, Quehenberger F, Chott A, Beham-Schmid C, Höfler G, Linkesch W, Raderer M.

J Clin Oncol. 2002 Sep 15;20(18):3872-7.

PMID:
12228207
14.

Effective combination chemotherapy with paclitaxel and cisplatin with or without human granulocyte colony-stimulating factor and/or erythropoietin in patients with advanced gastric cancer.

Kornek GV, Raderer M, Schüll B, Fiebiger W, Gedlicka C, Lenauer A, Depisch D, Schneeweiss B, Lang F, Scheithauer W.

Br J Cancer. 2002 Jun 17;86(12):1858-63.

15.

Randomized phase II study of irinotecan plus mitomycin C vs. oxaliplatin plus mitomycin C in patients with advanced fluoropyrimidine/leucovorin-pretreated colorectal cancer.

Scheithauer W, Kornek GV, Brugger S, Ullrich-Pur H, Valencak J, Raderer M, Fiebiger W, Kovats E, Lang F, Depisch D.

Cancer Invest. 2002;20(1):60-8.

PMID:
11853004
16.

Absence of therapeutic efficacy of the somatostatin analogue lanreotide in advanced primary hepatic cholangiocellular cancer and adenocarcinoma of the gallbladder despite in vivo somatostatin-receptor expression.

Fiebiger WC, Scheithauer W, Traub T, Kurtaran A, Gedlicka C, Kornek GV, Virgolini I, Raderer M.

Scand J Gastroenterol. 2002 Feb;37(2):222-5.

PMID:
11843061
17.

Randomized multicenter phase II trial of oxaliplatin plus irinotecan versus raltitrexed as first-line treatment in advanced colorectal cancer.

Scheithauer W, Kornek GV, Raderer M, Ulrich-Pur H, Fiebiger W, Gedlicka C, Schüll B, Brugger S, Schneeweiss B, Lang F, Lenauer A, Depisch D.

J Clin Oncol. 2002 Jan 1;20(1):165-72.

PMID:
11773166
18.

Somatostatin-receptor scintigraphy for staging and follow-up of patients with extraintestinal marginal zone B-cell lymphoma of the mucosa associated lymphoid tissue (MALT)-type.

Raderer M, Traub T, Formanek M, Virgolini I, Osterreicher C, Fiebiger W, Penz M, Jäger U, Pont J, Chott A, Kurtaran A.

Br J Cancer. 2001 Nov 16;85(10):1462-6.

19.

Beta-2-microglobulin levels in patients with extranodal B-cell lymphoma of the mucosa-associated lymphoid tissue (MALT)-type: a retrospective analysis.

Penz MZ, Fiebiger WC, Valencak JB, Osterreicher C, Ba-Ssalamah A, Formanek M, Brodowic T, Chott A, Raderer M.

Anticancer Res. 2001 Jul-Aug;21(4B):3049-52.

PMID:
11712809
20.

Docetaxel as rescue medication in anthracycline- and ifosfamide-resistant locally advanced or metastatic soft tissue sarcoma: results of a phase II trial.

Köstler WJ, Brodowicz T, Attems Y, Hejna M, Tomek S, Amann G, Fiebiger WC, Wiltschke CH, Krainer M, Zielinski CC.

Ann Oncol. 2001 Sep;12(9):1281-8.

PMID:
11697841

Supplemental Content

Loading ...
Support Center